The Clinical Significance in Healthy Men of the Association Between Obesity Related Plasma Hemodilution and Tumor Marker Concentration

被引:37
作者
Chang, In Ho [1 ]
Ahn, Seung Hyun [2 ]
Han, June Hyun [2 ]
Kim, Tae-Hyoung [1 ]
Kim, Young Sun [1 ]
Myung, Soon Chul [1 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea
[2] Hanil Gen Hosp, KEPCO Med Fdn, Seoul, South Korea
关键词
prostatic neoplasms; obesity; tumor markers; biological; hemodilution; body mass index; PROSTATE-SPECIFIC ANTIGEN; BODY-MASS INDEX; FATTY LIVER-DISEASE; PSA CONCENTRATION; CANCER; VELOCITY; RISK;
D O I
10.1016/j.juro.2008.10.030
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We investigated the association between body mass index and the concentration of tumor markers including carcinoembryonic antigen, alpha-fetoprotein, the carbohydrate antigen 19-9 and prostate specific antigen, as well as the association between body mass index changes and tumor marker concentration changes in a population of healthy men. Materials and Methods: We evaluated data on 8,776 men screened for tumor markers (carcinoembryonic antigen, a-fetoprotein, carbohydrate antigen 19-9 and prostate specific antigen) at least 3 times annually during an annual examination from 2001 to 2007. We assessed the tumor marker test findings for a trend in the age, alanine aminotransferase and creatinine adjusted tumor marker concentration by body mass index. We used multivariate regression analysis to determine whether a change in body mass index was associated with a tumor marker concentration change over time using calculated tumor markers, body mass index, creatinine and alanine aminotransferase concentration change per year. Results: After adjusting for age, creatinine and alanine aminotransferase a higher body mass index was associated with lower prostate specific antigen (p for trend <0.001), carcinoembryonic antigen (p for trend <0.001) and carbohydrate antigen 19-9 (p for trend <0.001). On multivariate regression analysis each I kg/m(2) of body mass index gain per year was associated with a -0.011 ng/ml change in prostate specific antigen concentration, a -0.030 ng/ml change in carcinoembryonic antigen concentration and a -0.192 IU/ml change in carbohydrate antigen 19-9 concentration per year. Conclusions: In this cohort of healthy men hemodilution from increased plasma volume may be responsible for the observed decreased tumor marker concentration in men with a higher body mass index. In addition, an increase in body mass index may predict a lower tumor marker concentration in an individual.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 20 条
[1]   Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers [J].
Andersson, SO ;
Wolk, A ;
Bergstrom, R ;
Adami, HO ;
Engholm, G ;
Englund, A ;
Nyren, O .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :385-389
[2]   The association of body mass index and prostate-specific antigen in a population-based study [J].
Baillargeon, J ;
Pollock, BH ;
Kristal, AR ;
Bradshaw, P ;
Hernandez, J ;
Basler, J ;
Higgins, B ;
Lynch, S ;
Rozanski, T ;
Troyer, D ;
Thompson, I .
CANCER, 2005, 103 (05) :1092-1095
[3]   Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer [J].
Banez, Lionel L. ;
Hamilton, Robert J. ;
Partin, Alan W. ;
Vollmer, Robin T. ;
Sun, Leon ;
Rodriguez, Carmen ;
Wang, Yiting ;
Terris, Martha K. ;
Aronson, William J. ;
Presti, Joseph C., Jr. ;
Kane, Christopher J. ;
Amling, Christopher L. ;
Moul, Judd W. ;
Freedland, Stephen J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (19) :2275-2280
[4]   Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [J].
Barba, C ;
Cavalli-Sforza, T ;
Cutter, J ;
Darnton-Hill, I ;
Deurenberg, P ;
Deurenberg-Yap, M ;
Gill, T ;
James, P ;
Ko, G ;
Miu, AH ;
Kosulwat, V ;
Kumanyika, S ;
Kurpad, A ;
Mascie-Taylor, N ;
Moon, HK ;
Nishida, C ;
Noor, MI ;
Reddy, KS ;
Rush, E ;
Schultz, JT ;
Seidell, J ;
Stevens, J ;
Swinburn, B ;
Tan, K ;
Weisell, R ;
Wu, ZS ;
Yajnik, CS ;
Yoshiike, N ;
Zimmet, P .
LANCET, 2004, 363 (9403) :157-163
[5]   Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program [J].
Barqawi, AB ;
Golden, BK ;
O'Donnell, C ;
Brawer, MK ;
Crawford, ED .
UROLOGY, 2005, 65 (04) :708-712
[6]   Dietary fat, calories, and prostate cancer risk [J].
Bosland, MC ;
Oakley-Girvan, I ;
Whittemore, AS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (06) :489-491
[7]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[8]   Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men [J].
Chang, In Ho ;
Han, Jun Hyun ;
Ahn, Seung Hyun .
JOURNAL OF UROLOGY, 2008, 179 (03) :886-890
[9]   Methods of calculating prostate-specific antigen velocity [J].
Connolly, David ;
Black, Amanda ;
Murray, Liam J. ;
Napolitano, Giulio ;
Gavin, Anna ;
Keane, Patrick F. .
EUROPEAN UROLOGY, 2007, 52 (04) :1044-1051
[10]   Pathogenesis and management issues for non-alcoholic fatty liver disease [J].
Duvnjak, Marko ;
Lerotic, Ivan ;
Barsic, Neven ;
Tomasic, Vedran ;
Jukic, Lucija Virovic ;
Velagic, Vedran .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (34) :4539-4550